Delivery Order SPE2DB22D2211-SPE2DB25FRRMD

Award Date 2/14/25
Potential Completion Date 3/10/25
Potential Value $6.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of XEOMIN 100 unit vials to the Defense Logistics Agency (DLA), a defense agency. The $2,711.80 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 17, 2024 with a completion date of January 9, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award is for the delivery of XEOMIN 100 unit vials, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,627.08 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 17, 2024, with a completion date of January 9, 2025. The contract is not set aside for any specific business designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of XEOMIN 100 unit vials, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm-fixed price Delivery Order with a ceiling value of $13,106 and an ultimate completion date of November 15, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,254.16 firm-fixed-price delivery order contract is for the supply of XEOMIN 100 unit vials, a specialty pharmaceutical product. The contract has an ultimate completion date of January 10, 2025 and was awarded on December 18, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,310.60 fixed-price delivery order is for the supply of XEOMIN 100 unit vials, with a completion date of November 12, 2024. This award is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which provides a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award, valued at $13,559.00, was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a delivery order for the provision of 4,566,773,316 units of the pharmaceutical product XEOMIN 200 UNIT VIALS. The contract has a firm fixed-price pricing type and an ultimate completion date of January 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,242.40, is for the delivery of 4,566 units of XEOMIN 100 unit vials. This is a firm fixed-price delivery order contract with a completion date of November 15, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
This federal contract award is for the delivery of XEOMIN 100 unit vials to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $1,627.08 and a ceiling value of $1,627.08. The ultimate completion date is January 9, 2025. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,155.52, is for the delivery of XEOMIN 200 UNIT VIALS, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as a...
This federal contract award is for the delivery of XEOMIN 100 unit vials to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $2,621.20. The contract is a delivery order with a firm fixed price, and the ultimate completion date is September 23, 2024. The place of performance is Conshohocken, PA. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB25FRRMD
    Delivery Order

This federal contract award is for the procurement of XEOMIN 100 unit vials, a pharmaceutical product, by the Defense Logistics Agency (DLA). The $6,704.88 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 10, 2025 and was awarded on February 14, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award reviewed was not designated with any set-aside requirements, indicating open competition.

Generated 5/16/25, 12:14 PM